Loading...
Loading...
Contributors:
Dataset URI:
10.1371/journal.pone.0131046.t001Metastases = at time of diagnosis of metastatic disease. Exact p-value = chi-square test except log-rank for survival. Synchronous disease = within 6 months after initial diagnose. Abbreviations: m = months, WBC; White blood cell count, ALP; alkaline phosphatase, UNL; Upper normal limit, CR; complete response, PR; partial response, PD; progressive disease, PFS; progression-free survival, ns; not significant.Patient characteristics and treatment comparing mCRC patients with tumor tissue available for tissue micro array (TMA) with patients where tumor tissue was not available for TMA.
Keyword(s):
7 m vs 11 m; BRAF mutation; BRAF mutations impact treatment; High BRAF Mutation Frequency; kras.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)